Article info
Multiple sclerosis
Original research
Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis
- Correspondence to Manuel Comabella, Multiple Sclerosis Centre of Catalonia, Neurology-Neuroimmunology Department, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain; manuel.comabella{at}vhir.org
Citation
Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis
Publication history
- Received February 4, 2022
- Accepted March 15, 2022
- First published April 29, 2022.
Online issue publication
July 13, 2022
Article Versions
- Previous version (29 April 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.